Clinical Trial

Taurine's Therapeutic Effect on Acute Radiation-induced Oral Mucositis and Dermatitis

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a single-center, double-blind, randomized controlled study. The patients were divided into control group and experimental group, 80 cases each. From the first day of radiotherapy to the end of radiotherapy, the experimental group was treated with 24 grams of taurine granule (containing 4.8 grams of taurine) before each day's radiotherapy. The control group was treated with the same amount of placebo.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2025-06-18; most recent amendment 2026-07-22.
Status change: Not Yet Recruiting → Recruiting 2025-12-21
Trial Details
NCT Number NCT07029178
Lead Sponsor Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Conditions Radiation Induced Oral Mucositis, Radiodermatitis
Enrollment 160 participants
Start Date 2025-11-24
Primary Completion 2027-11-01 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-23